Olivier Belenger files SEC Form 4 disclosures for Orgenesis Inc.. They have made 1 open-market trade across 1 company since 2017, most recently 2017-10-11.
CIK 0001706480
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ORGS | 5,904,716 | $12.5M |
Shares reported on the most recent Form 4, priced at the 2017-10-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORGS | SELL | 2017-10-11 | 2017-10-12 | $0.25 | $1.3M | +25.4% | +18.3% | +18.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.